PHARMACEUTICAL OVERAGE EVALUATION CHECKLIST

Created by ChecklistGuro (https://checklistguro.com)


--- INITIAL DATA GATHERING ---
[ ] Batch Number
[ ] Date of Overage Detection
[ ] Time of Overage Detection
[ ] Overage Type (e.g., API, Excipient, Impurity) (API, Excipient, Impurity, Other)
[ ] Original Quantity (Units)
[ ] Overage Quantity (Units)
[ ] Initial Observation/Description of Overage

--- ANALYTICAL REVIEW ---
[ ] Measured Overage Amount
[ ] Specification Limit
[ ] Acceptance Criteria (e.g., % allowable)
[ ] Analytical Method Used (HPLC, GC, UV-Vis, Titration, Other)
[ ] Analytical Data Comments/Observations
[ ] Date of Analysis
[ ] Attachment of Chromatogram/Analytical Report

--- PROCESS & MATERIAL INVESTIGATION ---
[ ] Describe the Manufacturing Process Step Involved
[ ] Material Source Verification Status (Verified, Pending, Not Applicable)
[ ] Batch Size at Time of Overage
[ ] Date of Material Receipt
[ ] Describe any deviations from standard operating procedures (SOPs)
[ ] Upload relevant batch records or reports
[ ] Potential Material Contributing Factors (Raw Material Specification, Supplier Change, Storage Conditions, Handling Procedures)

--- IMPACT ASSESSMENT ---
[ ] Estimated Overage Quantity (Units)
[ ] Potential Impact on Product Quality? (No Impact, Minor Impact, Moderate Impact, Significant Impact)
[ ] Potential Patient Safety Concerns? (None, Low, Moderate, High)
[ ] Detailed Explanation of Potential Quality Impacts
[ ] Potential Regulatory Reporting Requirements?
[ ] Date of Regulatory Notification (if applicable)
[ ] Estimated Cost of Overage (Material, Labor, Waste)

--- ROOT CAUSE DETERMINATION ---
[ ] Detailed Description of the Suspected Root Cause(s)
[ ] Potential Contributing Factors (Select all that apply) (Equipment Malfunction, Process Deviation, Human Error, Material Variation, Analytical Method Issue, Documentation Error)
[ ] Estimated Frequency of Similar Past Occurrences (if known)
[ ] Date of Initial Suspicion/Observation of Root Cause
[ ] Confidence Level in Root Cause Identification (High, Medium, Low) (High, Medium, Low)
[ ] Supporting Evidence & Data Analysis Related to Root Cause

--- CORRECTIVE AND PREVENTATIVE ACTIONS (CAPA) ---
[ ] Detailed Description of Corrective Action
[ ] Detailed Description of Preventative Action
[ ] Estimated Cost of Implementation (USD)
[ ] Planned Implementation Date
[ ] Responsible Department (Manufacturing, Quality Assurance, Engineering, Supply Chain)
[ ] Risk Level After Implementation (Low, Medium, High)
[ ] Quality Assurance Reviewer Signature

--- DOCUMENTATION REVIEW & APPROVAL ---
[ ] Summary of Findings and Assessment
[ ] Quality Assurance Reviewer Signature
[ ] Date of QA Review
[ ] Review Status (Approved, Rejected, Requires Revision)
[ ] Comments/Reason for Rejection (if applicable)
[ ] Reviewer Approval Signature (if Approved)
[ ] Date of Approval

--- VERIFICATION & FOLLOW-UP ---
[ ] CAPA Implementation Date
[ ] Number of Batches Reviewed Post-Implementation
[ ] Effectiveness of CAPA – Initial Assessment (Effective, Partially Effective, Ineffective)
[ ] Justification for CAPA Effectiveness Assessment (if not 'Effective')
[ ] Next Scheduled Review Date
[ ] Reviewer Signature
[ ] Summary of Follow-Up Observations & Findings

--- END OF TEMPLATE ---
Transform this text into a digital, automated, and trackable mobile app!
Visit: https://checklistguro.com/templates/pharmaceutical/pharmaceutical-overage-evaluation-checklist
(Click "Install Template" to launch your digital inspection tool immediately)